We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
+71.58%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
–
AUM
$1.12M
AUM Growth
-$871K
Cap. Flow
-$2.04M
Cap. Flow %
-182.44%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$1.8M
2
ALNA
Allena Pharmaceuticals
ALNA
+$236K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRRA
1
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.12M 100%
20,316
-34,338
-63% -$1.8M
ALNA
2
DELISTED
Allena Pharmaceuticals
ALNA
– –
-1,019,288
Closed -$236K

Similar funds

ACMV
August Capital Management VI Palo Alto, California $1.39M AUM
FRCMI
First Round Capital Management III Philadelphia, Pennsylvania $418K AUM
DB
DCVC Bio Palo Alto, California $313K AUM
NAM
Newfleet Asset Management Hartford, Connecticut $2.05M AUM 27.28% 1-Year Est. Return
ICMH
Integrity Capital Management (HK) Central, Hong Kong $64K AUM
AP
Atlas Principals Charlotte, North Carolina $2.19M AUM 56.71% 1-Year Est. Return
SP
Sage Partners Hong Kong $23K AUM
MGPI
Maveron General Partner IV Seattle, Washington $8K AUM

Frazier Management's Q2 2022 Portfolio in Review

As of Q2 2022, Frazier Management held 2 positions worth $1.12M, down 44% from $1.99M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Frazier Management withdrew a net $2.04M in Q2 2022, closing 1 position and reducing 1 holding. Its most notable exit was Allena Pharmaceuticals, an estimated $236K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Frazier Management's biggest Q2 2022 reduction was Sierra Oncology, Inc. Common Stock, cutting an estimated $1.8M.
  • Frazier Management fully exited Allena Pharmaceuticals in Q2 2022, selling an estimated $236K.
  • Frazier Management's ten largest holdings make up 100% of its $1.12M portfolio in Q2 2022.
  • Frazier Management opened 0 new positions and closed 1 in Q2 2022.
  • Frazier Management's portfolio value fell 44% quarter-over-quarter to $1.12M.

Based on Frazier Management's 13F filing for Q2 2022, filed 10 Aug 2022.